89 related articles for article (PubMed ID: 37084152)
1. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy.
Gervaso L; Bottiglieri L; Meneses-Medina MI; Pellicori S; Biffi R; Fumagalli Romario U; De Pascale S; Sala I; Bagnardi V; Barberis M; Cella CA; Fazio N
Clin Transl Oncol; 2023 Nov; 25(11):3287-3295. PubMed ID: 37084152
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials.
Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Randon G; Kook MC; An JY; Grabsch HI; Prisciandaro M; Nichetti F; Noh SH; Sohn TS; Kim S; Wotherspoon A; Morano F; Cunningham D; Lee J; Cheong JH; Smyth EC; Pietrantonio F
Eur J Cancer; 2024 May; 203():114043. PubMed ID: 38598921
[TBL] [Abstract][Full Text] [Related]
3. Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.
Vos EL; Maron SB; Krell RW; Nakauchi M; Fiasconaro M; Capanu M; Walch HS; Chatila WK; Schultz N; Ilson DH; Janjigian YY; Ku GY; Yoon SS; Coit DG; Vanderbilt CM; Tang LH; Strong VE
Ann Surg; 2023 May; 277(5):798-805. PubMed ID: 35766391
[TBL] [Abstract][Full Text] [Related]
4. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
Pietrantonio F; Miceli R; Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Morano F; Wotherspoon A; Valeri N; Kook MC; An JY; Grabsch HI; Fucà G; Noh SH; Sohn TS; Kim S; Di Bartolomeo M; Cunningham D; Lee J; Cheong JH; Smyth EC
J Clin Oncol; 2019 Dec; 37(35):3392-3400. PubMed ID: 31513484
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
[TBL] [Abstract][Full Text] [Related]
6. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer.
Furukawa K; Hatakeyama K; Terashima M; Urakami K; Koseki Y; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K
Gastric Cancer; 2024 May; ():. PubMed ID: 38744779
[TBL] [Abstract][Full Text] [Related]
7. Clinical Management of Gastric Cancer Treatment Regimens.
Boilève J; Touchefeu Y; Matysiak-Budnik T
Curr Top Microbiol Immunol; 2023; 444():279-304. PubMed ID: 38231223
[TBL] [Abstract][Full Text] [Related]
8. Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Zhou J; Shen J; Seifer BJ; Jiang S; Wang J; Xiong H; Xie L; Wang L; Sui X
Oncotarget; 2017 May; 8(18):30477-30494. PubMed ID: 27802185
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the human epidermal growth factor receptor 2 (
Huang H; Wang Z; Li Y; Zhao Q; Niu Z
J Gastrointest Oncol; 2021 Apr; 12(2):377-387. PubMed ID: 34012633
[TBL] [Abstract][Full Text] [Related]
10. Molecular Testing in Stage 4 Stomach Cancer in India: A Single-Centre Experience.
Anand R; Rauthan A; Patil P; Murthy NY
Cureus; 2023 Nov; 15(11):e49412. PubMed ID: 38024069
[TBL] [Abstract][Full Text] [Related]
11. [A Case of Late Recurrent MSI-High StageⅠB Gastric Cancer after Surgery].
Ikeshita T; Kuga T; Shigeta M; Yano Y
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1315-1317. PubMed ID: 38247071
[TBL] [Abstract][Full Text] [Related]
12. [Updates on immunotherapy of gastrointestinal cancers and practical challenges].
Chen F; Wang F; Xu RH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):24-34. PubMed ID: 38262897
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis.
Petrelli F; Antista M; Marra F; Cribiu' FM; Rampulla V; Pietrantonio F; Dottorini L; Ghidini M; Luciani A; Zaniboni A; Tomasello G
Ther Adv Med Oncol; 2024; 16():17588359241231259. PubMed ID: 38435432
[TBL] [Abstract][Full Text] [Related]
14. Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data.
Biondi A; Lorenzon L; Santoro G; Agnes A; Laurino A; Persiani R; D'Ugo D
Eur J Surg Oncol; 2023 Nov; 49(11):106969. PubMed ID: 37414627
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapies and Developing Precision Medicine in Gastric Cancer.
Pihlak R; Fong C; Starling N
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370858
[TBL] [Abstract][Full Text] [Related]
16. Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer.
Cavaliere A; Merz V; Casalino S; Zecchetto C; Simionato F; Salt HL; Contarelli S; Santoro R; Melisi D
J Gastric Cancer; 2019 Dec; 19(4):375-392. PubMed ID: 31897341
[TBL] [Abstract][Full Text] [Related]
17. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies.
Pous A; Notario L; Hierro C; Layos L; Bugés C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511163
[TBL] [Abstract][Full Text] [Related]
18. Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?
Seo JW; Park KB; Chin HM; Jun KH
PLoS One; 2023; 18(6):e0283366. PubMed ID: 37285389
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy.
Kavun A; Veselovsky E; Lebedeva A; Belova E; Kuznetsova O; Yakushina V; Grigoreva T; Mileyko V; Fedyanin M; Ivanov M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190216
[TBL] [Abstract][Full Text] [Related]
20. Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives.
Takahari D; Nakayama I
Int J Clin Oncol; 2023 Nov; 28(11):1431-1441. PubMed ID: 37500970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
